The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
Open accessAbstract
Autologous induced pluripotent stem cells (iPSCs) constitute an unlimited cell source for patient-specific cell-based organ repair strategies. However, their generation and subsequent differentiation into specific cells or tissues entail cell line-specific manufacturing challenges and form a lengthy process that precludes acute treatment modalities. These shortcomings could be overcome by using prefabricated allogeneic cell or tissue products, but the vigorous immune response against histo-incompatible cells has prevented the successful implementation of this approach. Here we show that both mouse and human iPSCs lose their immunogenicity when major histocompatibility complex (MHC) class I and II genes are inactivated and CD47 is over-expressed. These hypoimmunogenic iPSCs retain their pluripotent stem cell potential and differentiation capacity. Endothelial cells, smooth muscle cells, and cardiomyocytes derived from hypoimmunogenic mouse or human iPSCs reliably evade immune rejection in fully MHC-mismatched allogeneic recipients and survive long-term without the use of immunosuppression. These findings suggest that hypoimmunogenic cell grafts can be engineered for universal transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“These gene-edited iPSCs could differentiate into endothelial cells and cardiomyocytes that demonstrated long-term survival in humanized mouse models without any immunosuppression.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [118]
The cited source says what the claim attributes to it.
In the citing paper
“Overexpression of CD47 has also been successfully implemented to mitigate innate immune responses after HLA deletion.”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature reviews. Immunology · doi:10.1038/nri2017 · Cited by 1,393
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts
Shiba, Y., Gomibuchi, T., Seto, T., Wada, Y., Ichimura, H., Tanaka, Y., Ogasawara, T., Okada, K., Shiba, N., Sakamoto, K., et al. (2016) · Nature · doi:10.1038/nature19815 · Cited by 840
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Melkus, M. W., Estes, J. D., Padgett‐Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T., & Garcia, J. V. (2006) · Nature Medicine · doi:10.1038/nm1431 · Cited by 653
Self-citationHLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Fetomaternal immune cross-talk and its consequences for maternal and offspring's health
Arck, P., & Hecher, K. (2013) · Nature Medicine · doi:10.1038/nm.3160 · Cited by 609
Wunderlich, M., Chou, F.-S., Link, K. A., Mizukawa, B., Perry, R. L., Carroll, M., & Mulloy, J. C. (2010) · Leukemia · doi:10.1038/leu.2010.158 · Cited by 415
Chang, C., Fontes, J., Peterlin, M., & Flavell, R. (1994) · Journal of Experimental Medicine · doi:10.1084/jem.180.4.1367 · Cited by 352
Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bartunek, J., Marbán, E., Aßmus, B., Henry, T. D., Traverse, J. H., et al. (2015) · Circulation Research · doi:10.1161/circresaha.116.304346 · Cited by 313
Cited by
Sorted by citations
Items 501–600 of 758
Chino, S., Ichimura, H., Tohyama, S., Kobayashi, H., Shiina, T., Sakai, H., Fukuda, K., Tomita, T., Yamada, M., Tateishi, A., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf249 · Cited by 4
Wu, X., Jin, S., Pan, Y., Zhen, W., Yu, S., Zhang, Y., Xu, F. Y., Wang, R., Wu, M., Sun, W., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-04997-4 · Cited by 7
Factors Affecting Stem Cell–Based Regenerative Approaches in Retinal Degeneration
Patel, S. H., & Lamba, D. A. (2023) · Annual Review of Vision Science · doi:10.1146/annurev-vision-120222-012817 · Cited by 4
Engineered heart tissue patches: A milestone in cardiac regenerative medicine
van Mil, A., Janssen, J., & van Rooij, E. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.02.012 · Cited by 4
Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature
Guo, M. Z., Watanabe, T., & Shinoka, T. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16050152 · Cited by 4
“Свой среди чужих”: можно ли создать гипоиммуногенные линии плюрипотентных стволовых клеток?
Bogomiakova, M. E., Валерьевич, Е. А., & Lagarkova, M. A. (2019) · Molecular Biology · doi:10.1134/s0026898419050045 · Cited by 4
Progress and promise of cell sheet assisted cardiac tissue engineering in regenerative medicine
Abdolahzadeh, H., Rad, N. K., Shpichka, A. I., Golroo, R., Rahi, K., Timashev, P. S., Hassan, M., & Vosough, M. (2023) · Biomedical Materials · doi:10.1088/1748-605x/acbad4 · Cited by 4
Beaver, D., & Limnios, I. J. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1130086 · Cited by 5
iPS‐derived pericytes for neurovascular regeneration
Kirabali, T., & Rust, R. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13601 · Cited by 3
Misra, P. S., & Nostro, M. C. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100321 · Cited by 4
A new paradigm in transplant immunology: At the crossroad of synthetic biology and biomaterials
Zhang, Z., Ding, L.-Y., Zuo, X.-L., Feng, H., & Xia, Q. (2023) · Med · doi:10.1016/j.medj.2023.05.002 · Cited by 6
The past, present, and future promise of pluripotent stem cells
Seo, J., Saha, S., & Brown, M. E. (2024) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2024.100077 · Cited by 4
Introductory Chapter: Gene Editing Technologies and Applications
Chen, Y. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85499 · Cited by 5
Establishment of universal human embryonic stem cell lines
Kong, M., & Zhou, D. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.12.001 · Cited by 4
Karbassi, E., & Murry, C. E. (2022) · Circulation · doi:10.1161/circulationaha.122.059079 · Cited by 4
Engineered CD47 protects T cells for enhanced antitumor immunityPreprint
Yamada‐Hunter, S. A., Theruvath, J. L., McIntosh, B. J., Freitas, K. A., Radosevich, M., Leruste, A., Dhingra, S., Martínez-Vélez, N., Xu, P., Delaidelli, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.20.545790 · Cited by 4
Editorial: Methods and advances in induced pluripotent stem cells—ophthalmology
Armstrong, L., & Lako, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1298956 · Cited by 4
Stem‐Cell‐Based Small‐Diameter Blood Vessels with 3D Printing
Wang, Y., Wang, X., Chen, J., Wallace, G. G., & Gu, Q. (2024) · Small Science · doi:10.1002/smsc.202400261 · Cited by 3
Wang, Y., Sun, Y., Zhang, X.-W., Wang, S., Huang, X., Xu, K., Liu, Y., Huang, Y., Xu, J., Wei, X., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c13644 · Cited by 3
Kamatani, T., Kimura, R., Ikeda, S., Inoue, M., & Seino, K.-I. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413398122 · Cited by 4
Wan, Y., Wang, S., Li, H., Sun, X., Guo, M., Li, H., Huang, L., Kong, X., Cheng, Q., Zhou, Z., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202517779 · Cited by 3
Idnani, R., & Khan, S. (2025) · Bioprinting · doi:10.1016/j.bprint.2025.e00463 · Cited by 4
Wu, L., Shen, S., Qian, C., Wu, N., Qiu, X., & Hou, H. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02080h · Cited by 3
Overview of the major clinical trials investigating stem cells–based therapies for diabetes
Lin, T.-M., Lin, C.-H., Lin, C.-S., & Lin, C.-S. (2026) · Diabetes & Metabolism · doi:10.1016/j.diabet.2026.101738 · Cited by 4
Human thyroid organoids: tools for understanding thyroid diseases and development
Romitti, M., & Costagliola, S. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01249-6 · Cited by 3
Stem cell treatments and Parkinson's disease: Science and misconceptions
Stamper, A., Bulstrode, H. J. C. J., & Barker, R. A. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261434672 · Cited by 3
Adoptive Immunotherapy: A Human Pluripotent Stem Cell Perspective
Jin, G., Chang, Y., Harris, J. D., & Bao, X. (2023) · Cells Tissues Organs · doi:10.1159/000528838 · Cited by 4
Immune Shielding of Human Heart Valves
Peters, M. M. C., Zaldumbide, A., Groeneveld, E. J., Rabelink, M. J. W. E., Peerlings, J. H. D., van den Bogaerdt, A., Bouten, C. V. C., Hoeben, R. C., Goumans, M., & van Wijk, A. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.07.003 · Cited by 3
Stem and progenitor cell-based therapy of myelin disorders
Goldman, S. A., Franklin, R. J. M., & Osório, M. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00015-0 · Cited by 3
Gantier, M., Ménoret, S., Fourrier, A., Delbos, F., Nguyen, T. H., & Anegón, I. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1507317 · Cited by 3
Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer
Niizuma, K., Nishimura, T., Villanueva, J., Amaya, L., Fowler, J. L., Isobe, T., Nakauchi, Y., Saavedra, B., Xu, H., Nakanishi, M., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101517 · Cited by 3
Induced pluripotent stem cell technology: venturing into the second decade
Shi, Y., Inoue, H., Takahashi, J. B., & Yamanaka, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00095-2 · Cited by 4
Methods for Differentiating hiPSCs into Vascular Smooth Muscle Cells
Li, M., Luo, J., Ellis, M. W., Riaz, M., Ajaj, Y., & Qyang, Y. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1708-3_3 · Cited by 3
Krog, R. T., de Miranda, N. F. C. C., Vahrmeijer, A. L., & Kooreman, N. G. (2021) · Cancers · doi:10.3390/cancers13225789 · Cited by 3
Cell-based passive immunization for protection against SARS-CoV-2 infection
Sawula, E., Miersch, S., Jong, E. D., Li, C., Chou, F.-Y., Tang, J. K., Saberianfar, R., Harding, J. S., Sidhu, S. S., & Nagy, A. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03556-5 · Cited by 3
Jang, S., Shin, S., Jeong, Y., & Lim, D. (2023) · Organoid · doi:10.51335/organoid.2023.3.e16 · Cited by 3
Chen, X., Fan, K., Lu, J., Zhang, S., Dong, J., Qin, J., Fan, W., Wang, Y., Zhang, Y., Huo, P. F., et al. (2024) · Research · doi:10.34133/research.0338 · Cited by 3
Gheitasi, M., Safdel, S., Patra, S. K., Zandvakili, R., Nemati, M., Saha, B., & Jafarzadeh, A. (2024) · Human Immunology · doi:10.1016/j.humimm.2024.110836 · Cited by 3
Hu, X., White, K. A., Olroyd, A. G., Friera, A. M., Wang, C., Caruso, C. B., Connolly, A. J., Deuse, T., & Schrepfer, S. (2025) · iScience · doi:10.1016/j.isci.2025.112806 · Cited by 3
Self-citationHeart regeneration: from mouse to human
Weinberger, F., & Eschenhagen, T. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.10.010 · Cited by 3
Klimanskaya, I. V., Kimbrel, E. A., & Lanza, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00024-1 · Cited by 3
Secreted cytokines provide local immune tolerance for human stem cell-derived isletsPreprint
Gerace, D., Zhou, Q., Kenty, J. H.-R., Sintov, E., Wang, X., Boulanger, K. R., Li, H., & Melton, D. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.09.487072 · Cited by 3
Diminished Immune Cell Adhesion in Hypoimmune ICAM-1 Knockout Pluripotent Stem CellsPreprint
Saha, S., Haynes, W. J., Rio, N. M. D., Young, E. E., Zhang, J., Seo, J., Huang, L., Holm, A. M., Blashka, W., Murphy, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.07.597791 · Cited by 3
The future of ex vivo hematopoietic stem cell gene editing: what’s next
Cavazza, A., & Santilli, G. (2025) · Regenerative Medicine · doi:10.1080/17460751.2025.2480003 · Cited by 3
Pluripotent stem cell-derived cardiomyocyte transplantation: marching from bench to bedside
Yi, H., Liu, J., Wang, W., Li, H., Kong, W., Li, X., Zhang, W., Pahlavan, S., Tang, Y., Wang, X., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2801-x · Cited by 2
Navigating challenges in human pluripotent stem cell-derived islet therapy for type 1 diabetes
Usama, M., Deng, Y., Chen, Y., Milland, T., Malleshaiah, M. K., & Aghazadeh, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625439 · Cited by 4
Wexler, Y., Grinstein, H., Huber, I., Glatstein, S., Ghiringhelli, M., Edri, O., Landesberg, M., Shiff, D., Arbel, G., Rosh, I., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102603 · Cited by 2
Berger, T. G., Borisova, E., Gamerschlag, A., Terheyden-Keighley, D., Martins, S., & Greber, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-17876-4 · Cited by 2
Li, G., Massumi, M., Owji, H., Yang, G., Girda, E., & Hatefi, A. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114584 · Cited by 2
Zhou, M., Brinson, D., Lei, C., & Karoubi, G. (2025) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1155/term/8367426 · Cited by 2
Zhang, J., Sumide, K., Kanie, K., Ishikawa, A., Yoshida, M., Ishii, T., Wang, B., & Kaneko, S. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101060 · Cited by 2
Karaoglu, I. C., Odabas, A., Onder, T. T., & Kızılel, S. (2025) · bioRxiv · doi:10.3389/fimmu.2026.1759835 · Cited by 2
Curle, A. J., Fazal, S. V., Qarin, S., Howlett, S. K., He, X., Stamper, A., Pisupati, V., Barker, R. A., & Jones, J. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102818 · Cited by 3
Antibody-dependent cellular phagocytosis in cancer immunotherapy: research and perspectives
Gu, Q., Li, S., Hou, S., Liu, J., Zhang, X., Xi, Y., Chen, H., Liu, S., Chu, M., & Yang, M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08020-5 · Cited by 3
Mao, L., Ding, L., & Ding, Y. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04313-9 · Cited by 3
Zhang, K., Li, Z., O’Dair, M. K., Qu, D., Mealy, A., Nguyen, D., Cheng, H., Huang, D., Gopalakrishnan, S., Roberts, Z. J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71904-z · Cited by 2
Plaisse, C., Bézie, S., & Guillonneau, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1797186 · Cited by 2
Biofabrication of Vascularized Tissues
Schimelman, J. B., Sun, Y., Lyu, C., Lu, T.-Y., Yao, E. J., Huang, L., Altera, A. K., Xiang, Y., & Chen, S. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00914 · Cited by 2
Chen, X.-X., Yin, Z., Zhang, X., Hao, J., Zhou, Q., Yu, J., & Wu, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1772547 · Cited by 2
Modeling immune responses to autologous and allogeneic human stem cell–derived islet grafts in vivo
Genzano, C. B., Zanetti, G., Du, Traum, D., Lahori, D., Downes, G. M., Bhatele, S., Ding, X., Apley, K. D., Firdessa-Fite, R., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.200738 · Cited by 2
Zhang, H., Menasché, P., Fan, J., Gao, L., Luo, H., Xue, Y., Zhu, X., Wang, Q., Li, C., Xu, Y., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04605-1 · Cited by 3
Self-citationHalliez, C., Ibrahim, H., Otonkoski, T., & Mallone, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1076683 · Cited by 3
Murata, T., Hama, N., Kamatani, T., Mori, A., Otsuka, R., Wada, H., & Seino, K.-I. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.05.020 · Cited by 2
iPSCs-Based Therapy for Trabecular Meshwork
Zhu, W., Zhang, X., Wu, S., Wang, N., & Kuehn, M. H. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_671 · Cited by 2
Lee, J. S., Lee, J. E., Yu, S.-H., Chun, T., Chang, M., Lee, D. R., & Park, C. (2023) · International Journal of Stem Cells · doi:10.15283/ijsc23037 · Cited by 2
Barinova, A., Сергеевна, П. А., Александровна, Г. П., Ruchko, E. S., & Валерьевич, Е. А. (2024) · Medicine of Extreme Situations · doi:10.47183/mes.2024.001 · Cited by 2
Emborg, M. E., Gambardella, J. C., Zhang, A., & Federoff, H. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00010-1 · Cited by 2
Li, S.-L., Zheng, Y.-Y., Xue, H., Zhang, H.-W., Wu, J.-Y., Chen, X.-H., Bouza, M. P., Yi, S., Zhou, H.-X., Xia, X.-G., et al. (2025) · Biology · doi:10.3390/biology14070791 · Cited by 1
Pang, L. K., Huang, M.-F., Gingold, J. A., Pena, M., Zhao, R., & Lee, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00004-9 · Cited by 2
Innovations in Human Stem Cell Research: A Holy Grail for Regenerative Medicine
Liao, Y., Zhu, H., Ivanova, L. B., & Cairo, M. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88790 · Cited by 2
Re‐entering the pluripotent state from blood lineage: promises and pitfalls of blood reprogramming
Chen, Y., Yi, Y., Xu, J., Chan, W., & Loh, Y. (2019) · FEBS Letters · doi:10.1002/1873-3468.13659 · Cited by 2
Human stem cell-derived microglia will be an indispensable toolbox for Alzheimer’s disease research
Liu, T. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.306087 · Cited by 2
Induced pluripotent stem-cell-derived corneal grafts and organoids
Pulimamidi, V. K., Maddileti, S., & Mariappan, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823809-7.00005-0 · Cited by 2
Induced pluripotent stem cells–derived hematopoietic progenitors for cellular immunotherapies
Slukvin, I. I., D'Souza, S. S., & Kumar, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85545-7.00007-7 · Cited by 2
Overview of current technologies for tissue engineering and regenerative medicine
Kommeri, R., Agrawal, D. K., & Thankam, F. G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824064-9.00004-6 · Cited by 3
Reprogramming cell fates towards novel cancer immunotherapies
Leung, E. H. W., Joves, K., Petenkaya, A., Barham, G., Henderson, T. G., Liang, J., & Chronis, C. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102312 · Cited by 2
More Bang for Your Buck: “Off-The-Shelf” Solutions for Cell Replacement Therapy
Meissner, T., & Cowan, C. (2020) · StemJournal · doi:10.3233/stj-200002 · Cited by 2
Molecular scissors cut in on stem cells
Azvolinsky, A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0467-6 · Cited by 2
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
Beck, J. D., Birtel, M., Haefner, E. S., Keil, I. S., Reidenbach, D., Salomon, N., Yildiz, I., & Diken, M. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1675459 · Cited by 2
Zhang, L., Tian, L., Dai, X., Yu, H., Wang, J., Lei, A., Zhao, W., Zhu, Y., Sun, Z., Zhang, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.28.011270 · Cited by 2
Restoring glucose homeostasis with stomach-derived human insulin-secreting organoidsPreprint
Huang, X., Gu, W., Zhang, J., Lan, Y., Colarusso, J. L., Li, S., Pertl, C., Lu, J., Kim, H., Zhu, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.15.520488 · Cited by 2
“Off the Shelf” CAR ‐T/ NK Cells
Marín, N. D., Zhou, A. Y., Jacobs, M. T., & Fehniger, T. A. (2024) · Wiley eBooks · doi:10.1002/9781119824572.ch23 · Cited by 2
From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation
Motomura, T., Faccioli, L. A. P., Soto–Gutiérrez, A., Tafaleng, E. N., Díaz‐Aragon, R., Kocas‐Kilicarslan, Z. N., Haep, N., Florentino, R. M., Amirneni, S., Cetin, Z., et al. (2022) · Seminars in Liver Disease · doi:10.1055/a-1934-5404 · Cited by 2
Scaling of cell and gene therapies to population
Knöbel, S., & Bosio, A. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00012-5 · Cited by 1
Immunology of cell and gene therapy approaches for neurologic diseases
Widner, H. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00018-6 · Cited by 1
Advancing the Battle against Cystic Fibrosis: Stem Cell and Gene Therapy Insights
Shah, D. D., Chorawala, M. R., Pandya, A. J., Kothari, N. R., Prajapati, B. G., & Parekh, P. S. (2024) · Current Medical Science · doi:10.1007/s11596-024-2936-5 · Cited by 1
The cell replacement therapeutic potential of human pluripotent stem cells
Taei, A., Sajadi, F., Salahi, S., Enteshari, Z., Falah, N., Shiri, Z., Abasalizadeh, S., Hajizadeh‐Saffar, E., Hassani, S., & Baharvand, H. (2024) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2024.2443079 · Cited by 1
Stem Cells Advancement and Applications: A Regenerative Medicines
Thakur, P., Nirmala, D., Kaur, J., Kaushal, P., Bhardwaj, A., & Pandit, V. R. (2025) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v15i2.6979 · Cited by 2
iPSC Technology Applying in Cell Therapy
Chuang, J.-H., & Chang, Y.-F. (2025) · Springer eBooks · doi:10.1007/978-981-96-1261-1_24 · Cited by 1
Systematic Errors in Tumor Volume Estimation: Noise Modeling in Digital Caliper Measurements
Puskás, M., Ferenci, T., Kovács, L., & Drexler, D. A. (2025) · IEEE International Symposium on Applied Computational Intelligence and Informatics (SACI) · doi:10.1109/saci66288.2025.11030142 · Cited by 1
Xia, N., Li, J., Hu, B., Pan, B., Jiang, X., Wei, B., Pera, R. A. R., & Fang, F. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.053 · Cited by 1
CRISPR-Based Functional Genomics in Pluripotent Stem Cells
Zahedi, S. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-11019-y · Cited by 1
Jafari, Z., Hamzehpour, Z., Faghihi, M., Derazi, R. A., Makoui, M. H., Makoui, R. H., Fekri, S. M., Ansari, N. E., & Athari, S. S. (2025) · Modern Rheumatology · doi:10.1093/mr/roaf112 · Cited by 1
Jeyagaran, A., & Schenke‐Layland, K. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115766 · Cited by 1
Cardiac regeneration: The present state and future direction of human pluripotent stem cell therapy
Umei, T. C., & Tohyama, S. (2026) · Journal of Cardiology · doi:10.1016/j.jjcc.2026.01.006 · Cited by 1
Faried, A., Rudiman, R., Adam, A., Rusmana, D., Azis, R., Kusuma, H. S. W., Nurjamil, A. M., & Widowati, W. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-01993-6 · Cited by 1
Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes by spectral flow cytometry
Maeding, N., Kundully, D. S., Steinhuber, A., Kriedemann, N., Hernandez-Bautista, C. A., Martins, S., Hochmann, S., Martin, W., Mayr, W. R., Jungbauer, C., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1736994 · Cited by 1
Lin, Y., Yan, Y., Qu, C., Li, X., Abdulwahid, A.-H. R. R., & Shu, M. (2026) · BMC Plastic and Reconstructive Surgery · doi:10.1186/s44452-026-00016-w · Cited by 1
CRISPR/Cas9-mediated B2m knockout paves the way for allogeneic basal cell transplantation
Chen, H.-J., Luo, W., Ma, N., & Li, S.-Y. (2026) · Respiratory Research · doi:10.1186/s12931-026-03595-5 · Cited by 1
Fang, M.-H., Feng, H., Xu, K., Hai, T., Chen, S., Ren, J.-L., Wang, W., Wang, Y., Zou, J., Xu, F., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3162-2 · Cited by 1
Metadata
- Authors
- Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., Davis, M. M., Lanier, L. L., & Schrepfer, S.
- Affiliations
- University of California, San Francisco (US)
- Universität Hamburg (DE)
- University of North Carolina at Chapel Hill (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Schrepfer, Sonja
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2019-02-18
- Volume
- 37
- Issue
- 3
- Pages
- 252-258
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC6419516
- OpenAlex
- W2911604931
- Cited by
- 758
- References
- 31
- Citations by year
- 2026: 98 · 2025: 102 · 2024: 102 · 2023: 113 · 2022: 94 · 2021: 97 · 2020: 106 · 2019: 46
- FWCI
- 28.36
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-09-16)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL140236)
- National Institute of Mental Health (R01MH108179)
- National Institute of Allergy and Infectious Diseases (R01AI068129, R01AI111899, R01AI123010, U19AI057229)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, immune rejection, allogeneic transplantation, MHC mismatch, endothelial cells, smooth muscle cells, cardiomyocytes, immunosuppression-free transplantation
- MeSH terms
- Animals, Cell Differentiation, Graft Rejection, HLA Antigens, Humans, Transplantation, Homologous, Histocompatibility Antigens Class I, Myocytes, Cardiac, Mice, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
